BE899277A - Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation. - Google Patents

Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.

Info

Publication number
BE899277A
BE899277A BE0/212652A BE212652A BE899277A BE 899277 A BE899277 A BE 899277A BE 0/212652 A BE0/212652 A BE 0/212652A BE 212652 A BE212652 A BE 212652A BE 899277 A BE899277 A BE 899277A
Authority
BE
Belgium
Prior art keywords
active substance
antimycotics
spray
release
solution
Prior art date
Application number
BE0/212652A
Other languages
English (en)
French (fr)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE899277A publication Critical patent/BE899277A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE0/212652A 1983-03-30 1984-03-29 Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation. BE899277A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311700 DE3311700A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray

Publications (1)

Publication Number Publication Date
BE899277A true BE899277A (fr) 1984-10-01

Family

ID=6195161

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212652A BE899277A (fr) 1983-03-30 1984-03-29 Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.

Country Status (18)

Country Link
JP (1) JPS59184125A (OSRAM)
KR (1) KR840008283A (OSRAM)
AU (1) AU564979B2 (OSRAM)
BE (1) BE899277A (OSRAM)
CA (1) CA1212328A (OSRAM)
CH (1) CH660304A5 (OSRAM)
DE (1) DE3311700A1 (OSRAM)
ES (3) ES530845A0 (OSRAM)
FR (1) FR2543436B1 (OSRAM)
GB (1) GB2137090B (OSRAM)
GR (1) GR81880B (OSRAM)
IL (1) IL71363A0 (OSRAM)
IT (1) IT1173762B (OSRAM)
LU (1) LU85272A1 (OSRAM)
PH (1) PH20964A (OSRAM)
PT (1) PT78312B (OSRAM)
SE (1) SE8401747L (OSRAM)
ZA (1) ZA842336B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
US5246716A (en) * 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
DK0870497T3 (da) * 1995-12-14 2004-05-24 Taisho Pharmaceutical Co Ltd Aerosolpræparat
RU2117473C1 (ru) * 1996-05-28 1998-08-20 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии МЗ и ПМ РФ Способ наружного лечения микозов стоп и гладкой кожи
JP5160018B2 (ja) 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
CN118615240B (zh) * 2024-06-24 2024-12-27 江西普丽尔药业有限公司 一种联苯苄唑溶液剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JPS6018655B2 (ja) * 1976-01-01 1985-05-11 バイエル・アクチエンゲゼルシヤフト アゾリル−（１）−メタン類及びそれらの塩
JPS5598112A (en) * 1979-01-17 1980-07-25 Sumitomo Chem Co Ltd Liquid medicine for external use
DE3019027A1 (de) * 1980-05-19 1981-11-26 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
PT78312A (en) 1984-04-01
FR2543436B1 (fr) 1988-12-16
ES539274A0 (es) 1985-11-16
IT8420304A0 (it) 1984-03-29
DE3311700A1 (de) 1984-10-04
IL71363A0 (en) 1984-06-29
KR840008283A (ko) 1984-12-14
CH660304A5 (de) 1987-04-15
AU564979B2 (en) 1987-09-03
GB2137090B (en) 1986-07-09
ES8503946A1 (es) 1985-04-16
SE8401747L (sv) 1984-10-01
GB2137090A (en) 1984-10-03
CA1212328A (en) 1986-10-07
FR2543436A1 (fr) 1984-10-05
SE8401747D0 (sv) 1984-03-29
PH20964A (en) 1987-06-10
JPS59184125A (ja) 1984-10-19
ZA842336B (en) 1984-11-28
IT1173762B (it) 1987-06-24
PT78312B (en) 1986-06-02
LU85272A1 (de) 1984-11-14
ES539275A0 (es) 1985-11-16
AU2623584A (en) 1984-10-04
ES8601691A1 (es) 1985-11-16
GR81880B (OSRAM) 1984-12-12
ES530845A0 (es) 1985-04-16
ES8601690A1 (es) 1985-11-16
GB8408066D0 (en) 1984-05-10

Similar Documents

Publication Publication Date Title
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
MY100359A (en) External pharmaceutical composition.
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
BR9810712A (pt) Processo para a prevenção ou tratamento de prurido em um paciente
MY101791A (en) New benzimidazole derivatives
PT74703B (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
ATE91901T1 (de) Vehikel zur verabreichung von interferon.
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
ZA818499B (en) Agents for combating circulatory illnesses and their use
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
EP0240907A3 (en) Use of trans-4-û(2-amino-3,5-dibromobenzyl)amino¨cyclohexanol
NO941097L (no) Hudregenererende kosmetisk preparat
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
FR2525106B1 (fr) Composition cosmetique contenant en tant qu'agent actif sur l'elasticite et la souplesse de la peau, de la thiamorpholinone ou l'un de ses derives
PT80221B (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents
BE899278A (fr) Agent antimycotique a haute liberation de substance active sous forme d'une creme.
ES512643A0 (es) "nuevo procedimiento para la preparacion de acidos n-acil-l-alquilaminoguanidinicos y cualquiera de sus sales, como agentes tensioactivos de accion antimicrobiana".
IT8023161A0 (it) Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BAYER A.G.

Effective date: 20040329